TrialCancer science2023

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407.

Shunichi Sugawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.